antihemophilic factor, human recombinant residues 743-1636 deleted 1 UNT Injection

RxCUI: 1718993
RxNorm name: antihemophilic factor, human recombinant residues 743-1636 deleted 1 UNT Injection
Display name: antihemophilic factor, human recombinant residues 743-1636 deleted 1 UNT Injection
Full name: antihemophilic factor, human recombinant residues 743-1636 deleted 1 UNT Injection
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:38:58

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLA	Proprietary name	Proper name	License type	Status	Latest source
125264	Xyntha, Xyntha Solofuse	Antihemophilic Factor (Recombinant), Plasma/Albumin Free	351(a)	Rx	2026-09-01

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Adverse event summaries are temporarily unavailable. Other product information remains available.

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
52e97c7f-8240-4cd6-afd2-c452ab2f6e32	antihemophilic factor, human recombinant residues 743-1636 deleted 1 UNT Injection [PSN] · antihemophilic factor, human recombinant residues 743-1636 deleted 1 UNT Injection [SCD] · factor VIII, human recombinant residues 743-1636 deleted 1 UNT Injection [SY]	3	33	These highlights do not include all the information needed to use XYNTHA safely and effectively. See full prescribing information for XYNTHA. XYNTHA ® (antihemophilic factor [recombinant]) lyophilized powder for solution, for intravenous injection Initial U.S. Approval: 2008	20250227